NPCE Q2 2025 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena

NPCENeuroPace, Inc.

$482M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$24M+22.1% YoY

Gross Profit

$18M77.1% margin

Operating Income

-$7M-29.0% margin

Net Income

-$9M-36.8% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+4.4%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$106M

Total Liabilities

$87M

Stockholders' Equity

$19M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$19M	+22.1%
Gross Profit	$18M	$14M	+28.3%
Operating Income	-$7M	-$6M	-9.5%
Net Income	-$9M	-$8M	-15.1%

Geographic Segments

Non-US

$400,000100%